SUMF1
SUMF1 (sulfatase modifying factor 1), also known as formylglycine-generating enzyme (FGE) or UNQ3037, is an oxidase of the endoplasmic reticulum lumen. It converts a cysteine residue on target sulfatases into 3-oxoalanine, a modification required for their catalytic activity. Browse Assay Genie's current range of SUMF1 research reagents below, or read on for the biology behind the target.
SUMF1 is an oxidase that catalyses the conversion of cysteine to 3-oxoalanine on target proteins, using molecular oxygen and a reducing agent that has not yet been identified. This 3-oxoalanine residue is also called formylglycine (fGly) or C-alpha-formylglycine. It arises during the maturation of arylsulfatases and some alkaline phosphatases, which use the hydrated form of 3-oxoalanine as a catalytic nucleophile. Known substrates of the enzyme include GALNS, ARSA, STS and ARSE. By oxidising a cysteine in the active site of each substrate sulfatase, SUMF1 enables the hydrolysis of sulfate esters.
The human SUMF1 gene encodes a protein that resides in the lumen of the endoplasmic reticulum and belongs to the sulfatase-modifying factor family. HGNC places it in the oxidoreductase gene group, and the enzyme carries the EC number 1.8.3.7. Alternative splicing of the gene results in multiple transcript variants. The mouse ortholog is designated Sumf1, which is relevant to researchers using murine models of sulfatase biology.
The protein is best known as formylglycine-generating enzyme, or FGE, and the symbol UNQ3037 is also listed as an alias. Mutations in the SUMF1 gene cause multiple sulfatase deficiency, a lysosomal storage disorder. This link follows from the enzyme's role, because the loss of its activity affects the sulfatases that depend on the formylglycine modification. Researchers studying SUMF1 protein levels, SUMF1 gene expression or sulfatase activation therefore work across enzymology, post-translational modification and lysosomal disease research.
SUMF1 generates the formylglycine residue that arylsulfatases such as GALNS, ARSA, STS and ARSE need as a catalytic nucleophile, making it central to sulfatase activation.
Mutations in SUMF1 cause multiple sulfatase deficiency, a lysosomal storage disorder, so the enzyme is a focus for studies of disease mechanism.
SUMF1 converts cysteine to 3-oxoalanine using molecular oxygen, an unusual oxidative modification of target proteins that is studied in protein biochemistry.
As an oxidase in the endoplasmic reticulum lumen, SUMF1 is used to explore how luminal enzymes modify newly made sulfatases and alkaline phosphatases.
SUMF1 is an oxidase that converts cysteine to 3-oxoalanine (formylglycine) on target proteins, using molecular oxygen and an unidentified reducing agent. This modification is needed for arylsulfatases and some alkaline phosphatases, which use hydrated 3-oxoalanine as a catalytic nucleophile.
SUMF1 stands for sulfatase modifying factor 1. UniProt names the protein formylglycine-generating enzyme, abbreviated FGE, and UNQ3037 is also listed as an alias. The gene undergoes alternative splicing, which results in multiple transcript variants.
Mutations in SUMF1 cause multiple sulfatase deficiency, a lysosomal storage disorder. The mouse ortholog is Sumf1. For any product, check the datasheet for its validated reactivity before using it in a mouse study.
Known SUMF1 substrates, including sulfatases that depend on formylglycine modification, are listed here where products exist.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8NBK3; product specifications from Assay Genie datasheets.